Ticker
EW

Price
74.07
Stock movement down
-2.02 (-2.65%)
Company name
Edwards Lifesciences Corp
Exchange
(NYSE
,
Currency
USD
)
Sector
Healthcare >
Medical Devices
Market cap
45.06B
Ent value
46.77B
Price/Sales
8.37
Price/Book
7.76
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
29.61
Forward P/E
25.99
PEG
2.89
EPS growth
5.80%
1 year return
-19.47%
3 year return
-4.00%
5 year return
9.71%
10 year return
20.07%
Last updated: 2023-09-08
Get the latest news and real-time alerts from Edwards Lifesciences Corporation (EW) stock at Seeking Alpha.
September 26, 2023

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Edwards Lifesciences Corporation (EW) stock at Seeking Alpha.
September 26, 2023

iO Charts is a Seeking Alpha partner

DIVIDENDS

EW does not pay dividends or no data was received
Loading...
AD

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E29.61
Price to OCF36.99
Price to FCF46.28
Price to EBITDA29.10
EV to EBITDA30.21

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales8.37
Price to Book7.76
EV to Sales8.69
Edwards Lifesciences dominates the medical device market with its Transcatheter Aortic Valve Replacement technology. See why I rate EW stock a Strong Buy now.
August 21, 2023

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Edwards Lifesciences Corporation (EW) stock at Seeking Alpha.
August 5, 2023

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count608.31M
EPS (TTM)2.47
FCF per share (TTM)1.58

Income statement

Loading...
Income statement data
Revenue (TTM)5.38B
Gross profit (TTM)4.30B
Operating income (TTM)1.75B
Net income (TTM)1.52B
EPS (TTM)2.47
EPS (1y forward)2.85

Margins

Loading...
Margins data
Gross margin (TTM)79.93%
Operating margin (TTM)32.49%
Profit margin (TTM)28.28%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash769.00M
Net receivables699.10M
Total current assets3.10B
Goodwill1.16B
Intangible assets285.20M
Property, plant and equipment0.00
Total assets8.29B
Accounts payable201.90M
Short/Current long term debt691.30M
Total current liabilities1.02B
Total liabilities2.49B
Shareholder's equity5.81B
Net tangible assets4.36B

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)1.22B
Capital expenditures (TTM)244.60M
Free cash flow (TTM)973.60M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity26.21%
Return on Assets18.35%
Return on Invested Capital23.67%
Cash Return on Invested Capital15.15%
Loading...
AD

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open76.00
Daily high76.00
Daily low73.94
Daily Volume3.78M
All-time high130.68
1y analyst estimate87.62
Beta1.01
EPS (TTM)2.47
Dividend per share-
Ex-div date-
Next earnings date25 Oct 2023

Downside potential

Loading...
Downside potential data
EWS&P500
Current price drop from All-time high-43.32%-6.74%
Highest price drop-50.47%-56.47%
Date of highest drop1 Nov 20009 Mar 2009
Avg drop from high-11.41%-11.49%
Avg time to new high14 days13 days
Max time to new high516 days1805 days
Edwards Lifesciences Corporation (NYSE:NYSE:EW) Q2 2023 Earnings Conference Call July 26, 2023 5:00 PM ETCompany ParticipantsMark Wilterding - SVP, IR and...
July 27, 2023

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Edwards Lifesciences Corporation (EW) stock at Seeking Alpha.
July 26, 2023

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
EW (Edwards Lifesciences Corp) company logo
Marketcap
45.06B
Marketcap category
Large-cap
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Employees
17300
Investor relations
SEC filings
CEO
Michael Mussallem
Country
USA
City
Irvine
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
Get the latest news and real-time alerts from Edwards Lifesciences Corporation (EW) stock at Seeking Alpha.
July 26, 2023

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Edwards Lifesciences Corporation (EW) stock at Seeking Alpha.
July 25, 2023

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
Edwards Lifesciences certainly has the potential to grow as the underlying market will continue to grow at a high pace. Find out why EW stock is a Hold.
June 13, 2023
Edwards Lifesciences is the clear leader in the fast-growing TAVR market with a strong moat. Read more to know why I rate EW stock as a hold.
June 12, 2023
Medical device stocks, including Edwards Lifesciences, have struggled in recent years. Click here to read more about EW stock here.
June 12, 2023
Get the latest news and real-time alerts from Edwards Lifesciences Corporation (EW) stock at Seeking Alpha.
June 2, 2023
Edwards Lifesciences Corporation (NYSE:NYSE:EW) Q1 2023 Earnings Conference Call April 26, 2023 5:00 PM ETCompany ParticipantsMark Wilterding - SVP, IR and...
April 27, 2023
Get the latest news and real-time alerts from Edwards Lifesciences Corporation (EW) stock at Seeking Alpha.
April 26, 2023
Get the latest news and real-time alerts from Edwards Lifesciences Corporation (EW) stock at Seeking Alpha.
April 25, 2023
Get the latest news and real-time alerts from Edwards Lifesciences Corporation (EW) stock at Seeking Alpha.
April 11, 2023
Edwards Lifesciences has had an impeccable record of steadily rising earnings for more than two decades. Read more about EW stock here.
March 30, 2023
Edwards Lifesciences Corporation saw solid underlying growth in 2022, held back by a strong dollar. Click here for our analysis of EW stock prospects for 2023.
March 28, 2023
iO Charts is a Seeking Alpha partnerNext page